Literature DB >> 11057524

Chronic food restriction in rats augments the central rewarding effect of cocaine and the delta1 opioid agonist, DPDPE, but not the delta2 agonist, deltorphin-II.

K D Carr1, G Y Kim, S Cabeza de Vaca.   

Abstract

RATIONALE: Chronic food restriction augments the self-administration and locomotor stimulating effects of opiates, psychostimulants and NMDA antagonists. The extent to which these effects can be attributed to changes in drug pharmacokinetics and bioavailability versus sensitivity of the neuronal circuits that mediate the affected behavioral functions, has not been established. Recent studies point to central adaptive changes insofar as rewarding, locomotor and c-fos-inducing effects of amphetamine and MK-801, injected directly into the lateral ventricle, are greater in food-restricted than ad libitum fed rats. The increased expression of c-fos in nucleus accumbens (NAC) shell, in particular, suggests that food restriction may augment drug reward by modulating dopamine (DA) synaptic function in this area.
OBJECTIVES: The first purpose of this study was to investigate whether the rewarding effects of cocaine and the delta1 opioid agonist DPDPE, both of which increase DA synaptic transmission, are augmented by food restriction. The second purpose was to determine whether the delta2 opioid agonist, deltorphin-II, which has been reported to exert DA-independent rewarding effects, is subject to the potentiating effect of food restriction.
METHODS: Rewarding effects of drugs were measured in terms of their ability to lower the threshold for lateral hypothalamic self-stimulation (LHSS) using a rate-frequency method.
RESULTS: In separate experiments, cocaine (50, 100 and 150 microg, ICV) and DPDPE (10 and 25 microg, ICV) produced greater threshold-lowering effects in food-restricted than ad libitum fed rats. Deltorphin-II (5.0, 10 and 25 microg, ICV) had no effect on reward thresholds, regardless of feeding regimen.
CONCLUSIONS: While the reported DA-independence of deltorphin-II rewarding effects seemed to offer a means of testing the hypothesis that DA transmission is the critical modulated variable in food-restricted subjects, rewarding effects of this compound could not be demonstrated in the LHSS paradigm. The present results do, however, confirm and extend prior findings indicating that the enhanced self-administration of abused drugs by food-restricted subjects is due to enhanced sensitivity of a final common pathway for drug reward.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11057524     DOI: 10.1007/s002130000523

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Food restriction increases acquisition, persistence and drug prime-induced expression of a cocaine-conditioned place preference in rats.

Authors:  Danielle Zheng; Soledad Cabeza de Vaca; Kenneth D Carr
Journal:  Pharmacol Biochem Behav       Date:  2011-10-29       Impact factor: 3.533

2.  A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.

Authors:  Soledad Cabeza de Vaca; Lisa L Krahne; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2004-02-20       Impact factor: 4.530

3.  A comparison of the effects of different operant training experiences and dietary restriction on the reinstatement of cocaine-seeking in rats.

Authors:  Michele Bongiovanni; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2007-12-23       Impact factor: 3.533

4.  The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

Authors:  Dan Georgescu; Robert M Sears; Jonathan D Hommel; Michel Barrot; Carlos A Bolaños; Donald J Marsh; Maria A Bednarek; James A Bibb; Eleftheria Maratos-Flier; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

5.  Enhanced cocaine-conditioned place preference and associated brain regional levels of BDNF, p-ERK1/2 and p-Ser845-GluA1 in food-restricted rats.

Authors:  Shan Liu; Danielle Zheng; Xing-Xiang Peng; Soledad Cabeza de Vaca; Kenneth D Carr
Journal:  Brain Res       Date:  2011-05-19       Impact factor: 3.252

6.  The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysis.

Authors:  Robert C Twining; Christopher S Freet; Robert A Wheeler; Christian G Reich; Dennie A Tompers; Sarah E Wolpert; Patricia S Grigson
Journal:  Physiol Behav       Date:  2016-04-13

7.  AMPA receptor subunit GluR1 downstream of D-1 dopamine receptor stimulation in nucleus accumbens shell mediates increased drug reward magnitude in food-restricted rats.

Authors:  K D Carr; L S Chau; S Cabeza de Vaca; K Gustafson; M Stouffer; D S Tukey; S Restituito; E B Ziff
Journal:  Neuroscience       Date:  2009-11-24       Impact factor: 3.590

8.  Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of D-amphetamine and SKF-82958, and their augmentation by food restriction in rat.

Authors:  Kenneth D Carr; Soledad Cabeza de Vaca; Yanjie Sun; Lily S Chau; Yan Pan; Julie Dela Cruz
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

9.  Effects of time of feeding on psychostimulant reward, conditioned place preference, metabolic hormone levels, and nucleus accumbens biochemical measures in food-restricted rats.

Authors:  Danielle Zheng; Shan Liu; Soledad Cabeza de Vaca; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2013-01-25       Impact factor: 4.530

10.  Repeated binge access to a palatable food alters feeding behavior, hormone profile, and hindbrain c-Fos responses to a test meal in adult male rats.

Authors:  Nicholas T Bello; Angela S Guarda; Chantelle E Terrillion; Graham W Redgrave; Janelle W Coughlin; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.